ES2610472T3 - Derivados de quinolina como agentes antibacterianos - Google Patents

Derivados de quinolina como agentes antibacterianos Download PDF

Info

Publication number
ES2610472T3
ES2610472T3 ES06763888.2T ES06763888T ES2610472T3 ES 2610472 T3 ES2610472 T3 ES 2610472T3 ES 06763888 T ES06763888 T ES 06763888T ES 2610472 T3 ES2610472 T3 ES 2610472T3
Authority
ES
Spain
Prior art keywords
alkyl
compound
carbon atoms
halo
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES06763888.2T
Other languages
English (en)
Spanish (es)
Inventor
Anil Koul
Koenraad Jozef Lodewijk Andries
Jérome Emile Georges Guillemont
Magali Madeleine Simone Motte
David Francis Alain LANÇOIS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35447198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2610472(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2610472T3 publication Critical patent/ES2610472T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
ES06763888.2T 2005-06-28 2006-06-26 Derivados de quinolina como agentes antibacterianos Expired - Lifetime ES2610472T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05105755 2005-06-28
EP05105755 2005-06-28
PCT/EP2006/063552 WO2007000434A1 (en) 2005-06-28 2006-06-26 Quinoline derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
ES2610472T3 true ES2610472T3 (es) 2017-04-27

Family

ID=35447198

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06763888.2T Expired - Lifetime ES2610472T3 (es) 2005-06-28 2006-06-26 Derivados de quinolina como agentes antibacterianos

Country Status (31)

Country Link
US (1) US20130030016A1 (enExample)
EP (1) EP1898909B1 (enExample)
JP (1) JP5193857B2 (enExample)
KR (1) KR101329587B1 (enExample)
CN (1) CN101252927B (enExample)
AP (1) AP2547A (enExample)
AR (1) AR054804A1 (enExample)
AU (1) AU2006263882B2 (enExample)
BR (1) BRPI0613999B8 (enExample)
CA (1) CA2612614C (enExample)
CY (1) CY1119402T1 (enExample)
DK (1) DK1898909T3 (enExample)
EA (1) EA014431B1 (enExample)
ES (1) ES2610472T3 (enExample)
HR (1) HRP20170044T1 (enExample)
HU (1) HUE030264T2 (enExample)
IL (1) IL188395A (enExample)
JO (1) JO3322B1 (enExample)
LT (1) LT1898909T (enExample)
MX (1) MX2008000079A (enExample)
MY (1) MY173664A (enExample)
NO (1) NO341285B1 (enExample)
NZ (1) NZ564340A (enExample)
PL (1) PL1898909T3 (enExample)
PT (1) PT1898909T (enExample)
RS (1) RS55601B1 (enExample)
SG (1) SG166798A1 (enExample)
TW (1) TWI413520B (enExample)
UA (1) UA88701C2 (enExample)
WO (1) WO2007000434A1 (enExample)
ZA (1) ZA200711148B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JP5397881B2 (ja) * 2008-09-04 2014-01-22 昇一 城武 グラム陽性細菌用抗菌剤及び抗菌活性増強剤
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
ES2576491T3 (es) 2012-04-27 2016-07-07 Janssen Pharmaceutica, N.V. Derivados de quinolina antibacterianos
AU2018348796B2 (en) * 2017-10-13 2024-09-26 Adelaide university Zinc ionophores and uses thereof
CN110606825A (zh) * 2019-10-30 2019-12-24 成都海杰亚医药科技有限公司 一种制备吡啶-2-硫醇的方法
CN117843568A (zh) * 2024-01-03 2024-04-09 中国药科大学 一种芳烷基取代-1-甲基喹啉季铵盐类衍生物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
SI1527050T1 (sl) * 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji
MXPA06013888A (es) * 2004-05-28 2007-01-26 Janssen Pharmaceutica Nv Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos.
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CA2528849C (en) * 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents

Also Published As

Publication number Publication date
AU2006263882B2 (en) 2012-12-13
EA014431B1 (ru) 2010-12-30
US20130030016A1 (en) 2013-01-31
IL188395A (en) 2012-05-31
JO3322B1 (ar) 2019-03-13
NO341285B1 (no) 2017-10-02
ZA200711148B (en) 2013-03-27
PL1898909T3 (pl) 2017-03-31
CA2612614A1 (en) 2007-01-04
WO2007000434A1 (en) 2007-01-04
IL188395A0 (en) 2008-08-07
EP1898909A1 (en) 2008-03-19
TW200800183A (en) 2008-01-01
CY1119402T1 (el) 2018-03-07
NO20080499L (no) 2008-02-29
CN101252927B (zh) 2014-01-01
EA200800151A1 (ru) 2008-06-30
BRPI0613999A2 (pt) 2011-03-01
TWI413520B (zh) 2013-11-01
BRPI0613999B8 (pt) 2021-05-25
UA88701C2 (ru) 2009-11-10
BRPI0613999B1 (pt) 2020-04-22
RS55601B1 (sr) 2017-06-30
MX2008000079A (es) 2008-03-19
MY173664A (en) 2020-02-14
EP1898909B1 (en) 2016-10-19
KR20080028459A (ko) 2008-03-31
KR101329587B1 (ko) 2013-11-15
DK1898909T3 (en) 2017-02-06
NZ564340A (en) 2011-02-25
PT1898909T (pt) 2016-12-07
AU2006263882A1 (en) 2007-01-04
AR054804A1 (es) 2007-07-18
AP2547A (en) 2012-12-26
CA2612614C (en) 2017-07-25
CN101252927A (zh) 2008-08-27
JP2008546824A (ja) 2008-12-25
HK1120732A1 (en) 2009-04-09
LT1898909T (lt) 2017-02-10
JP5193857B2 (ja) 2013-05-08
HUE030264T2 (en) 2017-04-28
HRP20170044T1 (hr) 2017-03-10
SG166798A1 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
Joao Matos et al. Looking for new targets: simple coumarins as antibacterial agents
DK2099758T3 (en) ANTIBACTERIAL QUINOLIN DERIVATIVES
EA037366B1 (ru) Способ получения ингибитора parp, кристаллические формы и их применения
PT1912647E (pt) Derivados de quinolina como agentes antibacterianos
JP2012522807A (ja) 抗感染症薬としてのヒドロキシチエノキノロン類および関連化合物
ES2452736T3 (es) Derivados de quinolina como agentes antibacterianos
ME01127B (me) Antibakterijski derivati kvinolina
ES2414956T3 (es) Derivados de quinolina como agentes antibacterianos
BR112014003146B1 (pt) 3,4-dihidro-1h-[1,8]naftiridinonas substituídas com homopiperidinila antibacterianas, composição farmacêutica compreendendo os referidos composto e processos para preparação destes
ES2358048T3 (es) Nuevas isotiazoloquinolonas y compuestos relacionados como agentes antiinfecciosos.
ES2407824T3 (es) Derivados de quinolina antibacterianos
WO2008098143A2 (en) Antimicrobial compounds and methods of use
BRPI0609426B1 (pt) Naftiridonas e quinolonas de alquilidenil-heterocíclicas de 7-amino
BRPI0720251A2 (pt) Derivados de quinolina antibacterianos
TW200944532A (en) Novel 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
CN101631795A (zh) 基于红霉素的大环内酯
TWI385168B (zh) 作為抗菌劑之喹啉衍生物
Chai et al. Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines
CA2612614A1 (en) Quinoline derivatives as antibacterial agents
KR20090102778A (ko) 항균성 퀴놀린 유도체
Wang et al. Synthesis and in vitro antibacterial activity of 7-(3-Alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives
PT1898914E (pt) Derivados de quinolina como agentes antibacterianos
WO2021113795A1 (en) Compounds and methods for the treatment of cystic fibrosis
KR20080028460A (ko) 항박테리아제로서의 퀴놀린 유도체
ES2232309A1 (es) Procedimiento simplificado para la obtencion de gatifloxacino.